Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting
Achieve Life Sciences, Inc. - Common Shares (ACHV)
Last achieve life sciences, inc. - common shares earnings: 3/13 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.achievelifesciences.com
Company Research
Source: GlobeNewswire
SEATTLE and VANCOUVER, British Columbia, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company dedicated to the global development and commercialization of cytisinicline for the treatment of nicotine dependence, announced today an update on the ORCA-OL clinical trial, evaluating long-term exposure of the novel 3 mg cytisinicline treatment dosing regimen in individuals who smoke cigarettes or vape nicotine. Enrollment for the ORCA-OL trial has been completed with an enrollment of 479 participants at 29 clinical trial sites across the United States. All clinical sites and participants were previously involved in Achieve's ORCA “Ongoing Research of Cytisinicline for Addiction” program for smoking and e-cigarette cessation studies, which is thought to have facilitated the rapid enrollment of this trial in just over four months. Achieve believes that the 479 participants enrolled will be sufficient to meet the safety inform
Show less
Read more
Impact Snapshot
Event Time:
ACHV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACHV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACHV alerts
High impacting Achieve Life Sciences, Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ACHV
News
- Achieve Life Sciences, Inc. (NASDAQ: ACHV) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.MarketBeat
- Achieve Life Sciences Announces Participation at Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Achieve Life Sciences Announces Participation at Upcoming Investor ConferencesGlobeNewswire
- Achieve Life Sciences, Inc. (NASDAQ: ACHV) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $12.00 price target on the stock.MarketBeat
- Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]Yahoo! Finance
ACHV
Earnings
- 11/7/24 - Miss
ACHV
Sec Filings
- 11/19/24 - Form EFFECT
- 11/15/24 - Form EFFECT
- 11/12/24 - Form SC
- ACHV's page on the SEC website